Ketamine for Depression

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Wild Health, Lexington, KYDepression+1 MoreKetamine - Drug
Eligibility
18 - 64
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study whether ketamine can help treat depression or PTSD by measuring its impact on epigenetic aging.

Eligible Conditions
  • Post Traumatic Stress Disorder
  • Depression

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Ketamine
1
Ketamine
1
SRW Cel System

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Assessment will compare the difference in PHQ-9/PCL-5 scores from baseline to after treatment with change in biological age from baseline to post-treartment.

Assessment will compare the difference in PHQ-9/PCL-5 scores from baseline to after treatment with change in biological age from baseline to post-treartment.
Degree of Treatment Response
Assessment will evaluate the correlation of data collected at baseline with biological age assessed after treatment is complete, on average five weeks
Severity of Illness and post-treatment epigenetic age
Assessment will evaluate the correlation of data collected at baseline with data from after treatment is completed, on average five weeks
Severity of Illness and baseline epigenetic age
Biological age will be compared from baseline to study completion, an average of five weeks
Epigenetic Age

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Similar Trials

1
Ketamine
1
Ketamine
2
SRW Cel System

Trial Design

1 Treatment Group

Ketamine Infusion
1 of 1

Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Ketamine · No Placebo Group · Phase 2

Ketamine Infusion
Drug
Experimental Group · 1 Intervention: Ketamine · Intervention Types: Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ketamine
2011
Completed Phase 4
~1160

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: assessment will compare the difference in phq-9/pcl-5 scores from baseline to after treatment with change in biological age from baseline to post-treartment.

Who is running the clinical trial?

Wild HealthUNKNOWN
TruDiagnosticLead Sponsor
11 Previous Clinical Trials
466 Total Patients Enrolled

Eligibility Criteria

Age 18 - 64 · All Participants · 9 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are not of childbearing potential or using an acceptable form of birth control (females-only).
You have experienced a major depressive episode or a traumatic event in the past 4 weeks.
You have a reliable form of transportation to lodging or home following the completion of each ketamine infusion treatment day.

Who else is applying?

What state do they live in?
Tennessee33.3%
Kentucky22.2%
South Carolina11.1%
Other33.3%
How old are they?
18 - 65100.0%
What site did they apply to?
Wild Health100.0%
What portion of applicants met pre-screening criteria?
Met criteria77.8%
Did not meet criteria22.2%
Why did patients apply to this trial?
  • "I have been unsuccessfully cycling through medications for the past six years with no success. I have heard others have great success with ketamine therapy, so I want to participate in a trial as there is no possibility of my affording treatment outside of a trial atmosphere."
How many prior treatments have patients received?
3+100.0%
References

Frequently Asked Questions

Are recruitment efforts still ongoing for this clinical trial?

"Yes, this study requires more participants and was last updated on September 7th, 2022. The clinicaltrials website has the original posting date as April 1st, 2022." - Anonymous Online Contributor

Unverified Answer

Is this research project only available to adults aged 25 and up?

"Eligibility for this specific clinical trial is restricted to patients aged 18-64. Out of the 1164 clinical trials available for people over 65 and the 222 trials geared towards those under 18, this is the only one that meets your age criteria." - Anonymous Online Contributor

Unverified Answer

How many people total are included in this clinical trial?

"The clinical trial is still seeking participants, according to the information on clinicaltrials.gov. The study was originally posted on 4/1/2022 and was most recently edited on 9/7/2022. They are recruiting for 20 participants between 1 sites." - Anonymous Online Contributor

Unverified Answer

Is Ketamine a short-term or long-term solution?

"There is some data supporting Ketamine's safety, but nothing concretely linking it to efficacy. As such, we've given it a score of 2." - Anonymous Online Contributor

Unverified Answer

Might I be a right candidate for this clinical trial?

"The requirements for this study are that participants must have a diagnosis of depression and be within the specified age range. So far, 20 people have been enrolled in the trial." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top